An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic Fibrosis

BACKGROUND AND OBJECTIVE: Cysteamine is licensed for use in nephropathic cystinosis but preclinical data suggest a role in managing cystic fibrosis (CF). This study aimed to determine whether oral cysteamine is absorbed in adult CF patients and enters the bronchial secretions. Tolerability outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Devereux, Graham, Steele, Sandra, Griffiths, Kairen, Devlin, Edward, Fraser-Pitt, Douglas, Cotton, Seonaidh, Norrie, John, Chrystyn, Henry, O’Neil, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951511/
https://www.ncbi.nlm.nih.gov/pubmed/27153825
http://dx.doi.org/10.1007/s40261-016-0405-z

Ejemplares similares

Ejemplares similares